Literature DB >> 17006980

Do probiotics have a therapeutic role in gastroenterology?

Jimmy K Limdi1, Catherine O'Neill, John McLaughlin.   

Abstract

Several hundred species of bacteria inhabit the gut, and affect its cell biology, morphology and homeostasis. Many bacteria are however potential pathogens, especially if the integrity of the epithelial barrier is physically or functionally breached. Conversely, the interaction between host and commensal microbes can confer important health benefits. This has led to commercial and public interest in "probiotics", live microbes principally taken as food supplements. Might probiotics also be used in disease therapy? Experimental evidence that probiotics modulate gut physiology, particularly barrier integrity and immunological function, underpins exciting new gastroenterological research. We discuss below the scientific basis for probiotic effects and present a critical perspective for their use in relation to gastrointestinal disease.

Entities:  

Mesh:

Year:  2006        PMID: 17006980      PMCID: PMC4088225          DOI: 10.3748/wjg.v12.i34.5447

Source DB:  PubMed          Journal:  World J Gastroenterol        ISSN: 1007-9327            Impact factor:   5.742


  143 in total

Review 1.  Clostridium difficile in patients with renal failure - management of an outbreak using biotherapy.

Authors:  J Popoola; A Swann; G Warwick
Journal:  Nephrol Dial Transplant       Date:  2000-05       Impact factor: 5.992

2.  Analysis of intestinal flora development in breast-fed and formula-fed infants by using molecular identification and detection methods.

Authors:  H J Harmsen; A C Wildeboer-Veloo; G C Raangs; A A Wagendorp; N Klijn; J G Bindels; G W Welling
Journal:  J Pediatr Gastroenterol Nutr       Date:  2000-01       Impact factor: 2.839

Review 3.  Molecular physiology and pathophysiology of tight junctions I. Tight junction structure and function: lessons from mutant animals and proteins.

Authors:  L L Mitic; C M Van Itallie; J M Anderson
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2000-08       Impact factor: 4.052

4.  Lactobacillus GG administered in oral rehydration solution to children with acute diarrhea: a multicenter European trial.

Authors:  S Guandalini; L Pensabene; M A Zikri; J A Dias; L G Casali; H Hoekstra; S Kolacek; K Massar; D Micetic-Turk; A Papadopoulou; J S de Sousa; B Sandhu; H Szajewska; Z Weizman
Journal:  J Pediatr Gastroenterol Nutr       Date:  2000-01       Impact factor: 2.839

5.  The effect of probiotics on Clostridium difficile diarrhea.

Authors:  M Pochapin
Journal:  Am J Gastroenterol       Date:  2000-01       Impact factor: 10.864

6.  Lipopolysaccharide activates distinct signaling pathways in intestinal epithelial cell lines expressing Toll-like receptors.

Authors:  E Cario; I M Rosenberg; S L Brandwein; P L Beck; H C Reinecker; D K Podolsky
Journal:  J Immunol       Date:  2000-01-15       Impact factor: 5.422

7.  Prophylactic Lactobacillus GG reduces antibiotic-associated diarrhea in children with respiratory infections: a randomized study.

Authors:  T Arvola; K Laiho; S Torkkeli; H Mykkänen; S Salminen; L Maunula; E Isolauri
Journal:  Pediatrics       Date:  1999-11       Impact factor: 7.124

8.  Lactobacillus GG in the prevention of antibiotic-associated diarrhea in children.

Authors:  J A Vanderhoof; D B Whitney; D L Antonson; T L Hanner; J V Lupo; R J Young
Journal:  J Pediatr       Date:  1999-11       Impact factor: 4.406

9.  Butyrate and trichostatin A effects on the proliferation/differentiation of human intestinal epithelial cells: induction of cyclin D3 and p21 expression.

Authors:  S Siavoshian; J P Segain; M Kornprobst; C Bonnet; C Cherbut; J P Galmiche; H M Blottière
Journal:  Gut       Date:  2000-04       Impact factor: 23.059

10.  Trefoil peptide protection of intestinal epithelial barrier function: cooperative interaction with mucin glycoprotein.

Authors:  H Kindon; C Pothoulakis; L Thim; K Lynch-Devaney; D K Podolsky
Journal:  Gastroenterology       Date:  1995-08       Impact factor: 22.682

View more
  6 in total

1.  Ability of probiotic Lactobacillus casei DN 114001 to bind or/and metabolise heterocyclic aromatic amines in vitro.

Authors:  Adriana Nowak; Zdzislawa Libudzisz
Journal:  Eur J Nutr       Date:  2009-05-16       Impact factor: 5.614

Review 2.  Novel therapeutic approaches in IBS.

Authors:  Sylvie Bradesi; Emeran A Mayer
Journal:  Curr Opin Pharmacol       Date:  2007-11-19       Impact factor: 5.547

3.  Effect of probiotic Lactobacillus rhamnosus GG intervention on global serum lipidomic profiles in healthy adults.

Authors:  Riina-A Kekkonen; Marko Sysi-Aho; Tuulikki Seppanen-Laakso; Ilkka Julkunen; Heikki Vapaatalo; Matej Oresic; Riitta Korpela
Journal:  World J Gastroenterol       Date:  2008-05-28       Impact factor: 5.742

4.  Probiotic intervention has strain-specific anti-inflammatory effects in healthy adults.

Authors:  Riina-A Kekkonen; Netta Lummela; Heli Karjalainen; Sinikka Latvala; Soile Tynkkynen; Salme Jarvenpaa; Hannu Kautiainen; Ilkka Julkunen; Heikki Vapaatalo; Riitta Korpela
Journal:  World J Gastroenterol       Date:  2008-04-07       Impact factor: 5.742

5.  Bifidobacterium animalis subspecies lactis modulates the local immune response and glucose uptake in the small intestine of juvenile pigs infected with the parasitic nematode Ascaris suum.

Authors:  Gloria Solano-Aguilar; Terez Shea-Donohue; Kathleen B Madden; Alejandro Quinoñes; Ethiopia Beshah; Sukla Lakshman; Yue Xie; Harry Dawson; Joseph F Urban
Journal:  Gut Microbes       Date:  2018-07-19

Review 6.  Sphingolipids as Mediators in the Crosstalk between Microbiota and Intestinal Cells: Implications for Inflammatory Bowel Disease.

Authors:  Phillips-Farfán Bryan; Carvajal Karla; Medina-Torres Edgar Alejandro; Espinosa-Padilla Sara Elva; Fabrias Gemma; Camacho Luz
Journal:  Mediators Inflamm       Date:  2016-08-30       Impact factor: 4.711

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.